Banner for leaf pages 2

Bosentan (Tracleer)

Also known as Tracleer

Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States, the European Union and other countries by Actelion Pharmaceuticals for the management of PAH under the trade name Tracleer.

Source: Wikipedia

Estimated Total Cost: $5485.41 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed bosentan to treat pulmonary hypertension, coronary atherosclerosis, rabies, and blastomycosis.

What side effects are related?

Patients taking bosentan most commonly experience side effects like headache, flushing, and chest pain.

Ajax-loader Loading...